• linkedin
  • Increase Font
  • Sharebar

    Risk calculator predicts breakthrough UTIs in reflux patients

    A new study on the use of a reflux calculator, developed at Children’s Hospital of Orange County in Irvine, CA, suggests the web-based risk stratification and probability model helps to predict vesicoureteral reflux patients’ 2-year risk of breakthrough urinary tract infection (BTUTI).

    Urology Times Editorial Council member Barry A. Kogan, MD, of Albany Medical Center, Albany, NY, says the model could make a good contribution to the care of these pediatric patients.

    Read - Best of AUA 2015: Infection/Inflammation

    “As we have come to realize that vesicoureteral reflux has been over-diagnosed and over-treated, we are looking for ways to identify those cases in which reflux really is important. This novel risk calculator is an excellent concept that is easy to use and helps the clinician find those children at highest risk for recurrent pyelonephritis,” said Dr. Kogan, who was not involved with creation of the model.

    The authors, who published their findings online in the Journal of Urology (June 9, 2015), analyzed retrospective demographic and clinical data on 252 patients diagnosed with primary vesicoureteral reflux, who were followed for 2 years. In their analysis, they identified factors associated with BTUTI and developed a regression model to estimate each subject’s 2-year BTUTI probability. Then, they identified three risk groups and validated the model in a prospective cohort of 56 patients.

    NEXT: BTUTI risk factors identified

    Lisette Hilton
    Lisette Hilton, president of Words Come Alive, has written about health care, the science and business of medicine, fitness and wellness ...

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results